Neurocrine Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/02/2025 | 14.68 M | $1.62 B | -0.68% | 14.73% |
| VANGUARD GROUP INC | 05/09/2025 | 9.94 M | $1.10 B | -1.76% | 9.97% |
| DODGE & COX | 05/14/2025 | 5.53 M | $612.13 M | 83.48% | 5.55% |
| STATE STREET CORP | 05/15/2025 | 4.86 M | $537.75 M | -0.59% | 4.88% |
| JPMORGAN CHASE & CO | 05/12/2025 | 2.67 M | $295.41 M | 94.79% | 2.68% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 2.50 M | $276.80 M | 0.53% | 2.51% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 2.10 M | $232.04 M | 43.95% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.97 M | $217.41 M | 5.05% | 1.98% |
| BELLEVUE GROUP AG | 05/14/2025 | 1.82 M | $201.29 M | 0.00% | 1.83% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.54 M | $170.28 M | 3.29% | 1.54% |
| MORGAN STANLEY | 05/15/2025 | 1.52 M | $167.92 M | -3.50% | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2025 | 1.49 M | $164.68 M | 72.74% | 1.49% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 1.26 M | $138.84 M | 32.85% | 1.26% |
| BRAIDWELL LP | 05/15/2025 | 1.19 M | $131.83 M | 32.17% | 1.20% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 1.16 M | $128.23 M | 8.34% | 1.16% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.07 M | $118.85 M | -43.35% | 1.08% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 1.00 M | $110.62 M | 12.13% | 1.00% |
| NORTHERN TRUST CORP | 05/13/2025 | 957.28 K | $105.88 M | -2.51% | 0.96% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 934.64 K | $103.37 M | -0.37% | 0.94% |
| BROWN ADVISORY INC | 04/30/2025 | 895.54 K | $99.05 M | -0.31% | 0.90% |
| CITADEL ADVISORS LLC | 05/15/2025 | 889.03 K | $98.33 M | -64.97% | 0.89% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 828.68 K | $91.65 M | -4.78% | 0.83% |
| JENNISON ASSOCIATES LLC | 05/05/2025 | 804.47 K | $88.97 M | -1.98% | 0.81% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 792.48 K | $87.65 M | -6.09% | 0.79% |
| JANUS HENDERSON GROUP PLC | 05/15/2025 | 783.97 K | $88.72 M | -1.28% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 775.77 K | $85.80 M | 1.73% | 0.78% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 737.44 K | $81.56 M | -25.04% | 0.74% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 615.64 K | $68.10 M | 11.90% | 0.62% |
| FIRST TRUST ADVISORS LP | 05/14/2025 | 593.36 K | $65.63 M | 50.35% | 0.60% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 579.43 K | $64.08 M | -4.85% | 0.58% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 576.59 K | $63.77 M | 37.71% | 0.58% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 576.17 K | $63.72 M | -0.25% | 0.58% |
| INVESCO LTD. | 05/12/2025 | 567.32 K | $62.75 M | -40.25% | 0.57% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 561.07 K | $62.05 M | 15.92% | 0.56% |
| IEQ CAPITAL, LLC | 05/14/2025 | 537.02 K | $59.39 M | -3.74% | 0.54% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/05/2025 | 511.36 K | $56.56 M | -0.53% | 0.51% |
| FIERA CAPITAL CORP | 05/07/2025 | 494.48 K | $54.69 M | -0.93% | 0.50% |
| CITIGROUP INC | 05/12/2025 | 466.19 K | $51.56 M | 182.23% | 0.47% |
| THRIVENT FINANCIAL FOR LUTHERANS | 05/13/2025 | 447.58 K | $49.50 M | -39.33% | 0.45% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 426.93 K | $47.22 M | -7.55% | 0.43% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 05/14/2025 | 399.65 K | $44.20 M | -46.60% | 0.40% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 393.46 K | $43.52 M | 1,405.18% | 0.39% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 04/24/2025 | 387.81 K | $41.50 M | -19.30% | 0.39% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 387.57 K | $43.05 M | -36.58% | 0.39% |
| LEGAL & GENERAL GROUP PLC | 05/15/2025 | 382.93 K | $42.35 M | 10.77% | 0.38% |
| PRIMECAP MANAGEMENT CO/CA/ | 05/09/2025 | 382.44 K | $42.30 M | -2.86% | 0.38% |
| CLEARBRIDGE INVESTMENTS, LLC | 05/13/2025 | 342.30 K | $37.86 M | 7.20% | 0.34% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2025 | 337.16 K | $37.29 M | -5.04% | 0.34% |
| AXA S.A. | 05/15/2025 | 333.70 K | $36.91 M | 12.09% | 0.33% |
| CANDRIAM S.C.A. | 05/14/2025 | 330.84 K | $36.59 M | 8.84% | 0.33% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 804 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 14.68 M
VANGUARD GROUP INC: 9.94 M
DODGE & COX: 5.53 M
STATE STREET CORP: 4.86 M
JPMORGAN CHASE & CO: 2.67 M
RENAISSANCE TECHNOLOGIES LLC: 2.5 M
94.39% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 133.23 M shares in the last 24 months. This purchase volume represents approximately $16.48 B in transactions.